Search

Akkermansia muciniphila AK32 Strain for Improving Intestinal Function

The USPTO granted patent US12605414B2 to The Asan Foundation for an Akkermansia muciniphila AK32 strain (Accession No. KCTC 14172BP) and its use for preventing or improving intestinal damage. The patent covers the bacterial strain itself as well as a method for administering an effective amount of the strain or its culture as an active ingredient to treat intestinal damage. Three claims are included in the granted patent.